OpenResearchAlpha

Journal of the American Chemical Society · 12 Nov 2026

Magnetic Resonance Silent Activatable Probe with Massive Signal Amplification for Rapid Detection of Inflammation-Associated Fibrogenesis

Yuanlin Zhangh-index 12, Ilknur Ay, Fumitaro Masaki, Veronica Clavijo Jordan, Hua Ma, Iris Y. Zhou, Chloe Brasket, Dongjun Li, Lydia Pollard, Mariane Le Fur, Ivy A. Rosales, Stuti Shroff, Nicholas J. Rotile, Jessica Klein, Jinbin Pan, Tingting Zha, Eric M. Gale, Peter Caravanh-index 62

0
Citations
no database records one yet
0
Citations in 2026
so far
62
Leading author's h-index
Peter Caravan, in QAI's scholar index
60
References
works it cites, from open citation data

Citations by database

Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.

  • OpenCitations0
  • Crossref0

Citations per year

The current year is still counting.

  • 2026 so far0

Abstract

Abstract Biomarker-specific molecular imaging is vital in precision medicine. However, a fundamental challenge of most molecular imaging methods is the difficulty of distinguishing specific molecular signal from nonspecific signal arising from the distribution of the molecular probe. This is even more pronounced in metabolically active organs such as the kidney and liver where the probe may concentrate prior to elimination. As a result, almost all molecular imaging relies on delayed imaging to achieve specificity, but this constrains clinical throughput and impedes rapid assessment of the diseased organ. Here, we report a magnetic resonance (MR) probe, Fe(II)-IAFP2, which combines 3 drivers of relaxivity enhancement to decouple disease specificity from probe distribution. Fe(II)-IAFP2 is MR-silent in its Fe(II) state, producing negligible MR signal even at high concentrations. In inflammatory, fibrogenic microenvironments common to many diseases, rapid oxidation to Fe(III) activates MR enhancement, while reversible aldehyde-mediated binding to remodeled extracellular matrix further amplifies relaxivity and promotes retention at the site of tissue injury. This dual activation–retention mechanism enables robust signal generation within minutes of administration. In mouse models of renal and liver fibrogenesis, Fe(II)-IAFP2 generated disease-associated MR contrast within minutes after intravenous administration. Together, this work demonstrates an effective strategy for rapid, activity-based molecular MR imaging through the combination of pathological activation and complementary tissue retention.

What the data shows

  • No database records a citation yet, as is usual for a paper this new.
  • Peter Caravan has the highest h-index among the authors (62).

Graph

This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.

Citing paper shares an authorAuthor without a profileSize shows citations, or h-index for authors

Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.

Start with

Authors (18)

Each author's standing in QAI's scholar index: the works their ORCID iD is attached to, and for anyone whose ORCID record names a lab OpenResearch follows, their arXiv preprints matched by name and a shared co-author. Names are as printed on the paper.

ProfileMost-cited paper

Cited by 0 papers

Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.

0 shown
No citing papers for this filter.

References (60)

What it cites, from open citation data, with Crossref's record of each.

Sign in to see 40 more references

A free account opens the rest of the citing papers and references on every paper’s page.